Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-06
1993-04-13
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, 544255, 544262, 544265, 544278, 544280, A61K 31505, A61K 3152, C07D48700, C07D47300
Patent
active
052023281
ABSTRACT:
Novel substituted fused pyrimidinones of formula (I), which are useful as angiotensin II antagonists, are disclosed. ##STR1##
REFERENCES:
patent: 4870186 (1989-09-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
Chin et al., European Journal of Pharmacology, 157(1988) 13-21.
Piper et al., J. Med. Chem. (1980) 23(10) 1136-1139.
P. C. Wong et al., European J. Pharma., 202, p. 323 (1991).
Ziegler et al., J. Org. Che. 43(5) (1978).
Allen Eric E.
de Laszlo Stephen E.
Greenlee William J.
Patchett Arthur A.
DiPrima Joseph F.
Grumbling Matthew V.
Merck & Co. , Inc.
Nicholson William H.
Shah Mukund J.
LandOfFree
Substituted fused pyrimidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted fused pyrimidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted fused pyrimidinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155561